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confusion over the proper units (e.g. micrograms/milligrams),
prohibition of certain drugs for infants and poor compliance by
children Little is written in the medical literature concerning
errors in prescribing children’s medications in the community;
most reports focus on hospital prescribing habits. OBJECTIVES:
To evaluate the quality of community pediatricians’ prescrip-
tions. METHODS: On 13 randomly chosen days during a 10
month period (December, 2003 until October, 2004), a total of
312 prescriptions written by 54 pediatricians were reviewed in
four different pharmacies in the Shfela District of Macabi
Health-Care Services. The following criteria were used: the cor-
relation of the treatment prescribed to the diagnosis as stated in
the computerized medical record and the appropriateness of the
dosage for the child’s age and weight. A correct prescription was
deﬁned as one which met these criteria. An incorrect prescrip-
tion lacked one or both of these qualities. RESULTS: From the
312 prescriptions that were evaluated, 265 (83.9%) were found
to be properly written. In 29 (9.3%) the treatment prescribed
did not correlate to the recorded diagnosis, and in one (0.3%)
the dosage was incorrect. In three (0.9%) prescriptions, no
dosage was stipulated at all. In an additional 18 (5.7%), techni-
cal failures of the computerized ﬁle precluded seeing a diagno-
sis. CONCLUSION: A total of 83.9% of the prescriptions that
were reviewed were properly written. In most of those that failed
to correlate with the diagnosis, treatment was provided sympto-
matically (nose drops, antipyretic, etc.) As a result of this study,
technical failures that were identiﬁed in the information systems
were repaired. Physicians were provided information detailing
the proper use and dosage of symptomatic medications accord-
ing to age and weight.
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OBJECTIVES: To assess the utility of a new Health Employer
Data and Information Set (HEDIS) measure of quality of care 
of pediatric upper respiratory infections (URI) in an Israeli
HMO, develop a comparable measure, and estimate baseline
performance. METHODS: Data sources included physician 
visit and pharmacy purchase ﬁles. We selected physician visits 
in 2003 bearing diagnoses corresponding to ICD-9-CM 460 
(URI-nasopharyngitis), 465 (URI other/unspeciﬁed site), and 461
(sinusitis) among children ages three-months to 18 years. Visits
by children for whom antibiotics had been purchased in the pre-
ceding 30 days, or who had additional diagnoses were excluded.
Associated antibiotic use was deﬁned as purchase of any antibi-
otic prescribed by the physician who recorded the URI diagno-
sis within three days of the visit. RESULTS: A total of 160,781
ﬁrst encounters for URI or sinusitis met the inclusion criteria.
Nine percent were associated with an antibiotic purchase.
Antibiotic use for URI or sinusitis increased with age, from 4%
of visits in children under the age of one to 14% in children ages
15–18. Sixty-two percent of sinusitis, 7.1% of “nasopharyngi-
tis,” and 32% of “unspeciﬁed URI” visits were associated with
antibiotic use. CONCLUSION: Transfer of quality measures
between medical systems requires consideration of differences in
medical practice and of the ways in which diagnoses are used
and coded. In adapting the HEDIS measures of care of pediatric
upper respiratory infections, we chose to examine prescribing
practices within subgroups, as well as to explore sinusitis treat-
ment, an issue not currently addressed by HEDIS measures.
Overall antibiotic use in conjunction with diagnosis of URI in
our population was comparable to reported ﬁgures in US com-
mercial and Medicaid plans for the same year, but varied with
age and speciﬁc diagnosis. Additional attention to sinusitis treat-
ment, not currently addressed by HEDIS, is warranted.
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OBJECTIVES: To assess the utility of a new Health Employer
Data and Information Set (HEDIS) measure for care quality in
treatment of pediatric pharyngitis in an Israeli HMO, develop 
a comparable measure, and estimate baseline performance.
METHODS: Data sources included physician visit, pharmacy
purchase and laboratory result ﬁles. We selected physician visits
in 2003 bearing diagnoses corresponding to ICD-9-CM groups
034, 462 and 463 among children ages two to 18 years. Visits
by children for whom antibiotics had been purchased in the pre-
ceding 30 days or who had additional diagnoses were excluded.
Antibiotic treatment was deﬁned as purchase within three days
of the visit of any antibiotic prescribed by the physician who
recorded the diagnosis of pharyngitis. The ﬁrst encounter
meeting inclusion criteria for each child was selected. Testing for
streptococcal infection was deﬁned as a throat culture or rapid
strep test in laboratory ﬁles, or record of throat swab or rapid
test during a visit, any time from three days prior to the visit
until three days after the visit. RESULTS: Fifty-one percent of
visits for pharyngitis among children ages 2–18 years were asso-
ciated with an antibiotic prescription. A total of 76,399 ﬁrst
encounters for pharyngitis were associated with antibiotic treat-
ment in 2003; 34% were accompanied by strep testing. Fre-
quency of testing varied by administrative region, from 30% to
39%. CONCLUSIONS: Utilization of strep testing in associa-
tion with antibiotic treatment of pediatric pharyngitis (as 
measured according to HEDIS criteria) was low in Maccabi
Healthcare Services in 2003 in comparison to performance in US
commercial and Medicaid health plans. In calculating this
measure, we assumed complete reporting of rapid strep tests per-
formed in physicians’ ofﬁces. Reﬁnement of this measure will
require verifying this assumption, as underreporting by physi-
cians would result underestimation of performance.
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OBJECTIVES: This study determined the prevalence of poten-
tially inappropriate medication use in a nationally representative
sample of the non-institutionalized elderly population using the
updated Beers 2003 criteria. METHODS: Participants with age
65 years and older were selected from the Medical Expenditure
Panel Survey (MEPS) panel ﬁve for the period of January, 2000
to December, 2001, which was constituted by a series of ﬁve-
round interviews. The average duration within each round was
3.5, 5.0, 6.0, 6.0, and 3.5 months from round one to ﬁve, respec-
tively. Potentially inappropriate prescription medications were
identiﬁed using the NDC (National Drug Code). All the calcu-
lations of prevalence were adjusted by the weight variable in the
MEPS. RESULTS: Among the 1161 elderly participants in panel
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ﬁve, 402 patients were recognized having at least one inappro-
priate prescription during a two-year period, with a prevalence
of 34.6%. A total of patients (25.2%) had inappropriate med-
ication use in 2000 and 314 patients (27.5%) in 2001. The
prevalence was also calculated for ﬁve rounds, of which 178 par-
ticipants (15.8%) out of 1161 received at least one inappropri-
ate medication in round one, 201 participants (17.5%) in round
two, 215 (18.5%) in round three, 230 (20.2%) in round four,
and 184 (16.8%) in round ﬁve. The round-speciﬁc results indi-
cated that the prevalence did not shift dramatically during the
two-year period. Propoxyphene and amitriptyline were still the
most prevalently used inappropriate agents. CONCLUSIONS:
Since the updated Beers 2003 criteria changed with a net addi-
tion of 24 new agents compared to the 1997 list, the prevalence
of inappropriate prescriptions in the nation did not decrease after
four-years compared to the statistics reported by Zhan’s study
(2001), which analyzed a sample of 1996 MEPS. Necessary
interventions or policy making are still imperative in order to
effectively prevent the use of potentially inappropriate prescrip-
tions in the elderly.
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OBJECTIVES:To estimate prevalence of potentially inappropri-
ate medication prescribing (PIP) among elderly patients in two
outpatient practices and to determine the factors associated 
with PIP.METHODS: We conducted a retrospective chart review
in a general family medicine practice (FM) and a specialty 
geriatric practice (SG) for the six month time period of January
1, 2004–June 30, 2004. Inclusion criteria were age ≥65 years old,
being an established patient of the practice, and having at least
one visit during the study period. A sample of ﬁfty charts was
randomly identiﬁed from each practice. An occurrence of PIP
was deﬁned as having chart documentation of a prescription for
a medication on the 2003 revised Beers list of drugs to be avoided
in the elderly. RESULTS: In all, 21% of patients had at least one
occurrence of PIP. Of these, 24% of subjects had 2 or more
occurrences. Differences in PIP prevalences in FM and GS (18%
and 24% of subjects, respectively) were not statistically signiﬁ-
cant. Overall, the most frequent medications of concern were
oral estrogens and ﬂuoxetine. Multivariate analysis showed that
higher number of medications (≥9 medications vs. <5 medica-
tions, OR, 0.11; 95% CI, 0.02–0.69) was signiﬁcantly associ-
ated with lower odds of PIP occurrence. Age, race, gender,
number of clinic visits, and number of diagnoses were not sig-
niﬁcantly associated with PIP. CONCLUSIONS: Our retrospec-
tive chart review indicated that PIP in elderly patients was
common in both ambulatory settings, supporting results of prior
pharmacy database analyses. The fact that no signiﬁcant differ-
ences were found in PIP occurrence in the two practices and that
general demographic patient variables were not signiﬁcantly
associated with occurrence of PIP suggest that inappropriate 
prescribing may be endemic to physician prescribing patterns.
More research is needed to study physician prescribing patterns
in elderly populations and intervention strategies designed to
reduce PIP.
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OBJECTIVE: To examine prescription drug use among elderly
Medicare beneﬁciaries (EMBs) from a moral hazard perspective.
METHODS: Data for study came from the 2000 Medicare
Current Beneﬁciary Survey Cost and Use File. The sample
included all non-institutionalized EMBs ° 65 years and who
received or ﬁlled at least one prescription drug (Rx) in the past
year (n = 6046). Moral hazard was deﬁned as unit increase in
Rx use with unit increase in generosity of Rx coverage (ratio of
out of pocket expenditures to total Rx expenditures) or level of
cost sharing in presence of Rx insurance. Dependent variable was
per capita Rx events. Independent variables were Rx insurance
status and generosity of Rx coverage. T-test was conducted to
test statistical differences in mean number of Rx events by Rx
insurance status. Main effects of Rx insurance and generosity
were estimated using regression analysis. RESULTS: Mean
number of Rx events among EMBs with Rx insurance (n = 3634)
were 26.85 [95% CI = (26.10, 27.61), SE = 0.384]. The mean
number of Rx events among those without Rx insurance (n =
2412) were 25.2 [95% CI = (24.34, 25.20), SE = 0.442]. T- test
results revealed a statistical difference between the two means 
(p = 0.005). Regression analyses revealed that EMBs without Rx
insurance had about 10.86 percent [95% CI = (6.667, 14.956)],
p < 0.0001) fewer Rx events than those with Rx insurance. Rx
events increased signiﬁcantly with unit increase in generosity 
(p < 0.0001). CONCLUSION: Rx use among EMBs increased
in presence of Rx insurance and with increase in generosity sug-
gesting a moral hazard effect in their Rx use. As moral hazard
can increase overall Rx expenditures, policy makers and health
care providers must make efforts to limit increased Rx use attrib-
utable to reduced cost sharing and Rx insurance.
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OBJECTIVES: To determine the prevalence of chronic condi-
tions in managed care-enrolled Medicare seniors (age 65 plus)
and to examine the association between self-reported chronic
conditions and health status as measured by the SF-36.
METHODS: Data were obtained from the 2001 Medicare
Health Outcomes Survey (HOS). The HOS is conducted by the
Centers for Medicare and Medicaid Services to assess the quality
of care provided to Medicare beneﬁciaries enrolled in managed
care. The survey questionnaire, which was administered by
phone or mail, includes the SF-36 and items addressing demo-
graphic characteristics, depressive symptoms, and chronic con-
ditions. The SF-36 is comprised of eight multi-item scales, four
of which are considered “physical” domains and four are con-
sidered “mental” domains. For this analysis, number of chronic
conditions and the prevalence of each condition were described.
An ordinary least squares regression model was conducted for
each SF-36 scale to estimate the association between each
chronic condition and the scale scores after adjusting for demo-
graphic variables. RESULTS: More than 90% of respondents
had at least one chronic condition. Among the chronic condi-
tions, hypertension (57.6%), arthritis of the hip or knee (40.5%),
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